vimarsana.com

Latest Breaking News On - நாராயண் ராஜ் - Page 1 : vimarsana.com

American Cell Therapies Company Selects ValGenesis VLMS to Digitize Multiple Validation Lifecycle Processes

American Cell Therapies Company Selects ValGenesis VLMS to Digitize Multiple Validation Lifecycle Processes News provided by Share this article Share this article SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that a U.S. based cell therapies company has selected ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization. The company develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies. As a fast-growing organization with limited resources, the company is looking to the user-friendly ValGenesis VLMS to help them plan, define, and manage all validation operations, ensuring that the right amount of validation is applied to every system and asset being validated. ValGenesis VLMS will

International Biosciences Company to Digitize Validation Processes for its Clients Across 40 Countries, Driven by ValGenesis VLMS

International Biosciences Company to Digitize Validation Processes for its Clients Across 40 Countries, Driven by ValGenesis VLMS News provided by Share this article Share this article SAN FRANCISCO, Jan. 20, 2021 /PRNewswire/  ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems (VLMS), is pleased to announce that an international biosciences company has selected ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system. The company provides solutions for the most challenging life sciences problems. Their tools, services, and digital platforms empower scientists and engineers at every stage, helping them deliver breakthrough therapies worldwide. This global bioscience conglomerate plans to digitize the validation processes for its products and solutions through a single instance of ValGenesis VLMS with multilingual support that would be accessed by thousands of life science organizations across 40 count

Pioneering Gene Therapy Company Selects ValGenesis s SaaS Platform to Digitize Its Global Validation Programs

Pioneering Gene Therapy Company Selects ValGenesis s SaaS Platform to Digitize Its Global Validation Programs News provided by Share this article Share this article SAN FRANCISCO, Jan. 6, 2021 \/PRNewswire/  ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced that a pioneering gene therapy company has selected ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system, to digitize its corporate validation process. The company is committed to discovering, developing and delivering gene therapies that are helping patients overcome limitations in genetic disease. The company had decided to go paperless but took a while to study the digital validation solutions available in the market. Its aim was to select the one that fit most perfectly into its digital transformation strategy. In addition to its remote validation capability, ValGenesis VLMS was chosen for its ability to enable eff

ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites

ValGenesis Collaborates with Biocon Biologics for Digital Validation Across Multiple Sites News provided by Share this article Share this article SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/  ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that the Equipment Commissioning and Qualification (C&Q) process (validation life cycle) at Biocon Biologics has been digitized leveraging the power of ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system. Biocon Biologics, a subsidiary of Biocon, is an integrated pure play biosimilars organization addressing patients needs across the world, including developed markets like the U.S., Canada, EU and Australia, through its partners.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.